Market Overview:
The global antitumor antibiotics market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, rising demand for novel anticancer drugs, and technological advancements in the field of oncology. The global antitumor antibiotics market is segmented by type, application, and region. By type, the market is divided into etoposide, doxorubicin, daunorubicin, and bleomycin A5. By application, it is classified into breast cancer, thyroid cancer,, and others (ovarian cancer,, lymphoma,. leukemia,. etc.). The North America region dominates the global antitumor antibiotics market followed by Europe and Asia Pacific regions respectively. However.
Product Definition:
Antitumor antibiotics are a type of chemotherapy agent that destroy cancer cells. They are important for the treatment of many types of cancer, including breast cancer, lung cancer, and ovarian cancer.
Etoposide:
It is a cytotoxic drug that interferes with the cell division cycle. It belongs to the class of drugs known as Purine Antibiotics and Etoposide (Topoisomerase II Inhibitor) is used in cancer treatment. The major application of this drug is in chemotherapy for malignant tumors, including glioblastoma multiforme, lymphoma, breast carcinoma and lung carcinomatosis.
Doxorubicin:
Doxorubicin is a lipophilic (fat-soluble) antibiotic drug. It was first synthesized in 1960 and approved by the FDA for cancer treatment in 1965. Doxorubicin has been used as an anti-cancer agent since then with variable success, owing to its poor oral bioavailability and low activity against tumor cells with high resistance rates.
Application Insights:
Breast cancer held the largest revenue share of over 24.0% in 2017 owing to the increasing number of breast cancer cases globally. According to Breastcancer.org, around 1 in 8 U.S women develop invasive breast carcinoma during her lifetime and around 40% of these cases are diagnosed in people above 60 years old which is a high incidence rate for this disease especially in developed countries like U.
Regional Analysis:
Asia Pacific dominated the global arena in 2017, with a revenue share of over 47.0%. This can be attributed to the rising incidence of cancer and other diseases coupled with increasing disposable income and improved lifestyle. The region is expected to maintain its lead throughout the forecast period owing to ongoing initiatives by various governments as well as private organizations for early diagnosis & treatment of cancer & other diseases. For instance, in India, The Tata Institute for Fundamental Research (TIFR) has undertaken several projects related to drug discovery using antitumor antibiotics from natural sources like bacteria and fungi that are available in Asia Pacific countries.
North America held a significant market share in 2017 due to high R&D investments by major pharmaceutical companies along with government support for new drug development programs pertaining to oncology drugs including doxorubicin, epirubicin, daunorubicin among others which have shown promising results against advanced cancers such as breast cancer.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the antitumor antibiotics market. According to the American Cancer Society, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S., and approximately 595,690 people died from this disease. This number is expected to rise in the coming years due to growing population and aging population.
- Rising demand for targeted therapies: The rising demand for targeted therapies is another key growth driver for antitumor antibiotics market. Targeted therapies are drugs that are designed to attack specific cells or proteins associated with a particular type of cancer cell or tumor tissue type. They offer several advantages over traditional chemotherapy regimens such as improved efficacy and reduced toxicity profiles. As a result, there is an increasing demand for these drugs among patients with various types of cancers including lung cancer, breast cancer, colorectal cancer etc
Scope Of The Report
Report Attributes
Report Details
Report Title
Antitumor Antibiotics Market Research Report
By Type
Etoposide, Doxorubicin, Daunorubicin, Bleomycin A5
By Application
Breast Cancer, Thyroid Cancer, Others
By Companies
Shyndec Pharmaceutical, Qilu Antibiotics, Gansu Fuzheng, KPC Pharmaceuticals, China Resources Double Crane Pharmaceutical, Nippon Kayaku, Accord Healthcare, Teva Pharmaceutical, Mylan, Johnson & Johnson, Pfizer, Sun Pharmaceutical, Cadila Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Antitumor Antibiotics Market Report Segments:
The global Antitumor Antibiotics market is segmented on the basis of:
Types
Etoposide, Doxorubicin, Daunorubicin, Bleomycin A5
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Thyroid Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shyndec Pharmaceutical
- Qilu Antibiotics
- Gansu Fuzheng
- KPC Pharmaceuticals
- China Resources Double Crane Pharmaceutical
- Nippon Kayaku
- Accord Healthcare
- Teva Pharmaceutical
- Mylan
- Johnson & Johnson
- Pfizer
- Sun Pharmaceutical
- Cadila Pharmaceuticals
Highlights of The Antitumor Antibiotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Etoposide
- Doxorubicin
- Daunorubicin
- Bleomycin A5
- By Application:
- Breast Cancer
- Thyroid Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antitumor Antibiotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antitumor antibiotics are drugs that are used to treat cancer. They work by stopping the growth of cancer cells.
Some of the major players in the antitumor antibiotics market are Shyndec Pharmaceutical, Qilu Antibiotics, Gansu Fuzheng, KPC Pharmaceuticals, China Resources Double Crane Pharmaceutical, Nippon Kayaku, Accord Healthcare, Teva Pharmaceutical, Mylan, Johnson & Johnson, Pfizer, Sun Pharmaceutical, Cadila Pharmaceuticals.
The antitumor antibiotics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antitumor Antibiotics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antitumor Antibiotics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antitumor Antibiotics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antitumor Antibiotics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antitumor Antibiotics Market Size & Forecast, 2018-2028
4.5.1 Antitumor Antibiotics Market Size and Y-o-Y Growth
4.5.2 Antitumor Antibiotics Market Absolute $ Opportunity
Chapter 5 Global Antitumor Antibiotics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antitumor Antibiotics Market Size Forecast by Type
5.2.1 Etoposide
5.2.2 Doxorubicin
5.2.3 Daunorubicin
5.2.4 Bleomycin A5
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antitumor Antibiotics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antitumor Antibiotics Market Size Forecast by Applications
6.2.1 Breast Cancer
6.2.2 Thyroid Cancer
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antitumor Antibiotics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antitumor Antibiotics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antitumor Antibiotics Analysis and Forecast
9.1 Introduction
9.2 North America Antitumor Antibiotics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antitumor Antibiotics Market Size Forecast by Type
9.6.1 Etoposide
9.6.2 Doxorubicin
9.6.3 Daunorubicin
9.6.4 Bleomycin A5
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antitumor Antibiotics Market Size Forecast by Applications
9.10.1 Breast Cancer
9.10.2 Thyroid Cancer
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antitumor Antibiotics Analysis and Forecast
10.1 Introduction
10.2 Europe Antitumor Antibiotics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antitumor Antibiotics Market Size Forecast by Type
10.6.1 Etoposide
10.6.2 Doxorubicin
10.6.3 Daunorubicin
10.6.4 Bleomycin A5
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antitumor Antibiotics Market Size Forecast by Applications
10.10.1 Breast Cancer
10.10.2 Thyroid Cancer
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antitumor Antibiotics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antitumor Antibiotics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antitumor Antibiotics Market Size Forecast by Type
11.6.1 Etoposide
11.6.2 Doxorubicin
11.6.3 Daunorubicin
11.6.4 Bleomycin A5
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antitumor Antibiotics Market Size Forecast by Applications
11.10.1 Breast Cancer
11.10.2 Thyroid Cancer
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antitumor Antibiotics Analysis and Forecast
12.1 Introduction
12.2 Latin America Antitumor Antibiotics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antitumor Antibiotics Market Size Forecast by Type
12.6.1 Etoposide
12.6.2 Doxorubicin
12.6.3 Daunorubicin
12.6.4 Bleomycin A5
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antitumor Antibiotics Market Size Forecast by Applications
12.10.1 Breast Cancer
12.10.2 Thyroid Cancer
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antitumor Antibiotics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antitumor Antibiotics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antitumor Antibiotics Market Size Forecast by Type
13.6.1 Etoposide
13.6.2 Doxorubicin
13.6.3 Daunorubicin
13.6.4 Bleomycin A5
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antitumor Antibiotics Market Size Forecast by Applications
13.10.1 Breast Cancer
13.10.2 Thyroid Cancer
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antitumor Antibiotics Market: Competitive Dashboard
14.2 Global Antitumor Antibiotics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shyndec Pharmaceutical
14.3.2 Qilu Antibiotics
14.3.3 Gansu Fuzheng
14.3.4 KPC Pharmaceuticals
14.3.5 China Resources Double Crane Pharmaceutical
14.3.6 Nippon Kayaku
14.3.7 Accord Healthcare
14.3.8 Teva Pharmaceutical
14.3.9 Mylan
14.3.10 Johnson & Johnson
14.3.11 Pfizer
14.3.12 Sun Pharmaceutical
14.3.13 Cadila Pharmaceuticals
